IL1B and cholangiocarcinoma: A more recent study demonstrated how IL-1 beta (IL-1β) increased SM catabolism in a rodent model of CC by promoting a cachexia-associated gene expression pattern in the hypothalamic–pituitary–adrenal (HPA) axis, differently from IL-6 and IL-1α (54).